Aneesh Singhal, MD

Aneesh B. Singhal, MD, is Vice-Chair of Neurology Quality and Safety at Massachusetts General Hospital and Associate Professor of Neurology at Harvard Medical School in Boston, USA. He is a Board Certified Neurologist, Vascular Neurologist and, Neurosonologist. He serves on the Board of Trustees of the Partners Continuing Care and Spaulding Rehabilitation Network, is advisor to Partners HealthCare International and Neurology Foundation India. He is an elected Fellow to the American Neurological Association, the American Academy of Neurology, and the American Heart Association, and Past President of the Association of Indian Neurologists in USA.

Dr. Singhal’s areas of research include stroke clinical trials, stroke in young adults, cerebral arteriopathies, advanced brain imaging for acute ischemic stroke, and stroke neuroprotection. He is internationally recognized for his work on characterizing the reversible cerebral vasoconstriction syndrome (RCVS) and cerebral vasculitis. He is Deputy Principal Investigator of the New England Regional Coordinating Center (NERCC) for the NIH StrokeNet. He has served as the Principal Investigator of the NIH funded Indo-US Collaborative Stroke Project, the NIH funded Phase 2 trial of Normobaric Oxygen Therapy in Acute Stroke, and as site PI of several Industry funded stroke clinical trials. Dr. Singhal has authored or co-authored over 200 articles and book chapters.